Un artículo de nuestra colaboradora Irene Tarragó

It is obvious that lately I am absent-minded, because once again I have lost my mind and here I am, at this point of the month, writing my blog entry for the month of March.

We are living a horrible time with the war in Ukraine. Something that makes all the hardships seem like trivial difficulties in our lives. One of the first things I thought when the evil Putin decided to attack Ukraine and play with the lives of its citizens, was how would those people who have a chronic illness get medicines.  And I can’t understand how anyone could exist who would be so evil as to not allow medicines to get through, that the most vulnerable population could leave. Wars have always existed. But they have always been a grave mistake. From my point of view. Everybody always loses. Because many human lives are lost. And the lives of people who do not know each other and who do not want to be in that war are lost; while those who organize and prepare them stay in their palaces and do not suffer the rigors of war. No. I will always say NO TO WAR, although we cannot leave the Ukrainian people alone. And it is seen that Putin wants nothing by diplomatic means but full surrender.

Anyway. With that and with everything, life goes on. And this March 26 we celebrate World Epilepsy Day. It is also known as Purple Day. Purple Day was devised, in 2008 by Cassidy Megan, a Canadian girl affected by the disease, with the aim of dispelling old myths about the disease and raising awareness among patients that they are not alone.

And this March 26 we celebrate World Epilepsy Day.

It is also known as Purple Day.

There is a great need to raise awareness about epilepsy. It is not well known. The public still fears it and does not know what to do if they witness an epileptic seizure. We are the bearers of this information, and we must repeat it and repeat it. Let people know, not only about the disease, but also about people who have it and who explain it naturally. We can go through bad times, as in any other disease, but we do not have to carry a stigma that history, ignorance, religion and even cinema or literature have placed on us.

Leave a Reply

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.